Seeking Alpha

Biostar Pharmaceuticals looks for encore after huge gain, Q3 report

  • China-based Biostar Pharmaceuticals (BSPM) rises 4% premarket after posting Q3 results Thursday evening.
  • The company earned $0.03/share on revenue of $15M (+50% Y/Y). (PR)
  • Of note: BSPM rose 60% during regular trading Thursday.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs